Uflex Ltd Q3 FY2023 Concall Summary

Key Takeaways

• A quarter hit by a "conspiracy" of headwinds: Consolidated EBITDA fell ~28% YoY to ~INR 429 crores, driven by unprecedented notional FX losses (~INR 236 crores) and a cyclical downturn in the Offshore Packaging Films business.
• India Packaging is the resilient engine: Volume grew ~34% and revenue ~20%, with Flexible Packaging hitting its highest-ever monthly volume in January and Aseptic Packaging breaking seasonal barriers.
• Packaging Films margins have likely bottomed: Management believes there is "no more room left to reduce the margin" in BOPET and BOPP, with Q3 representing the trough as multiple negative factors converged.
• The balance sheet is under watch, not duress: Interest costs rose on higher global rates and new project commissioning, but debt covenants are manageable and no substantial net debt addition is expected.
• What to watch next quarter: Whether the promised Q4 recovery in Offshore Films materializes, the pace of volume recovery in Packaging Films, and the FY24 margin guidance that management will set after seeing Q4.

The Q3 Profitability Shock

• FX losses dominated the P&L: The ~INR 236 crores in exchange losses were mostly non-cash, driven by translation losses from Egypt's 22.3% currency devaluation in October and restatement of local-currency financials (Egypt, Mexico, Nigeria) into dollars and then rupees.
• Offshore Packaging Films de-grew on multiple fronts: Normal post-COVID seasonality returned, the Russia-Ukraine war inflated energy costs forcing consumers into "eat vs heat" trade-offs, aggressive US Fed policy hit consumption, and a strong dollar created availability issues in Nigeria and Egypt, cascading into lower local demand.
• Margins compressed across the board: Raw-material cost declines caused inventory losses, finished-goods prices fell, and consumption dropped, creating further pricing pressure. Management stated Q3 was the worst quarter because all these factors hit simultaneously.
• Interest costs added to the squeeze: Consolidated interest rose because the cost of debt increased (almost doubling in Nigeria, plus higher SOFR and euro benchmarks) and the CPP facilities in Dharwad and Dubai were commissioned, adding to the debt pool.

Rajesh Bhatia: “I’ll have to use the word, probably the entire universe conspired to reduce the margin.”

India Packaging: The Diversification Payoff

• Flexible Packaging turned a corner: After several years of underperformance, the business posted its highest-ever monthly volume in January, signaling a meaningful recovery.
• Aseptic Packaging broke its seasonal pattern: In prior years, capacity utilization dropped sharply in Aug–Sep; this year, export market growth kept utilization up even in non-seasonal months, and January saw 130% capacity utilization as the peak season began.
• Other India businesses compensated: While the Films business profitability suffered, Aseptic Packaging, Flexible Packaging, Inks, Adhesives, Chemicals, and Cylinders together offset the lower Films contribution, insulating consolidated India performance.
• Asepto capacity expansion is low-hanging fruit: The plan to debottleneck from 900 crore packs/year to nearly 1,200 crore packs/year requires no substantial investment, and the order book is already sufficient to serve customers at that level.

Rajesh Bhatia: “I don’t sort of -- I look at this quarter’s performance from a positive perspective in the looking at the Packaging business, Flexible Packaging, which has not been doing so well in the few years.”

Packaging Films: A Margin Floor in Sight

• Volumes declined with the market: Q3 sales volume fell ~6–7% sequentially to ~1,40,000 tons because overall market volumes shrunk, but management states market share was maintained or grown during the difficult period.
• BOPET and BOPP margins hit their lowest: Management believes Q2 or Q3 marked the trough and that there is no further room for margin reduction, though BOPET spreads remained at the same depressed level as Q3 into January–mid-February.
• Recovery is expected, not yet visible: Management expects only positive development from here, "not in Q4 but definitely in Q1," pinning hopes on a cyclical rebound as the external shocks fade.
• Currency devaluation has a silver lining: While painful in the short term, a large devaluation ultimately insulates the local business from import competition, a dynamic management flagged for Egypt and other affected markets.

Rajesh Bhatia: “I don’t think so, there is anymore room left to reduce the margin in both of them.”

Balance Sheet & Capex

• Debt is plateauing, not rising: Normal amortization is happening quarter-to-quarter per agreed bank schedules, and additional spend on Dharwad and Panipat projects will mean debt levels more or less offset; based on current plans, no substantial addition is expected.
• Covenant risk is contained but real: Management acknowledged possible quarterly covenant issues in European businesses on a trailing-12-month basis, but expects to get waivers from bankers who understand the energy-cost situation affecting all industries in the region.
• The capex cycle is winding down: No significant capex is planned after Dharwad and Panipat, except some small recycling plants, signaling a shift toward free cash flow generation once these projects are commissioned.
• Dharwad BOPET is imminent: Trial runs are underway, mechanical completion is done, and a power issue is being resolved; commercial production is expected by end-March or the first week of April, adding 68,000 tons/annum of capacity.

Rajesh Bhatia: "Whenever there are such scenarios, I think the bankers do understand that and will be hopeful that we will get waivers from them, because they also understand the situation in the European territory, particularly where the cost of energy has hit us, not only us, but across all the industries..."

Aseptic Packaging: The Hidden Growth Story

• Margins are sustainably healthy: Asepto delivers ~20% EBITDA with ups and downs between season and non-season, making it a structurally higher-margin business than the Films segment.
• Capacity expansion is de-risked: The move from 900 to 1,200 crore packs/year will happen "definitely in the next season," not the current one, and requires minimal investment because it is debottlenecking rather than greenfield.
• No near-term separation or listing: Management has no plans to separate or delist the business given its current size, but will reassess overseas subsidiary listing opportunities in Q3 FY24, the earliest possible window.
• Segmented disclosure remains off-limits: Management declined an analyst request for separate Aseptic Packaging financials, calling it "a bit confidential information," though they offered capacity utilization and capacity figures as proxies.

Guidance & Commitments

Key Metrics